tiprankstipranks
Trending News
More News >
Design Therapeutics Reports Strong Q3 and Pipeline Progress
PremiumCompany AnnouncementsDesign Therapeutics Reports Strong Q3 and Pipeline Progress
6M ago
Design Therapeutics reports Q3 EPS (23c), consensus (24c)
Premium
The Fly
Design Therapeutics reports Q3 EPS (23c), consensus (24c)
6M ago
Is DSGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is DSGN a Buy, Before Earnings?
7M ago
Design Therapeutics upgraded to Overweight from Neutral at Piper Sandler
PremiumThe FlyDesign Therapeutics upgraded to Overweight from Neutral at Piper Sandler
1y ago
Is DSGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is DSGN a Buy, Before Earnings?
1y ago
Design Therapeutics management to meet with Piper Sandler
Premium
The Fly
Design Therapeutics management to meet with Piper Sandler
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100